Frontlight ResearchEarly access
Trial site
University of Utah John A. Moran Eye Center
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration3 trials
- Glaucoma1 trial
- Retinitis pigmentosa1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Lead sponsor
- 4D Molecular Therapeutics1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Paul S. Bernstein1 trial
- Perceive Biotherapeutics, Inc.1 trial
- University of Utah1 trial
- and 1 more
Running trials
Enrolling by invitation
Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty
Recruiting
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Active, not recruiting
Active, not recruiting
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Glaucoma1 recruiting
- Macular degeneration1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026